½ÃÀ庸°í¼­
»óǰÄÚµå
1529986

¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå : ¼­ºñ½ºº°, »ê¾÷º°, Áö¿ªº°

Medical Affairs Outsourcing Market, By Services (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, Others), By Industry, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì(Medical Affairs Outsourcing) ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 23¾ï 1,000¸¸ ´Þ·¯¿¡¼­, 2024-2031³â¿¡ °ÉÃÄ CAGR 12.3%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÏ¿© 2031³â¿¡´Â 52¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ ¼¼ºÎÁ¤º¸
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 23¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â) CAGR : 12.30% 2031³â ±Ý¾× ¿¹Ãø 52¾ï 1,000¸¸ ´Þ·¯
±×¸². MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå Á¡À¯À²(%)(2024³â Áö¿ªº°)
Medical Affairs Outsourcing Market-IMG1

ÀǾàǰ °³¹ß ºñ¿ë »ó½Â°ú º¹ÀâÇÑ ±ÔÁ¦ ¿ä°ÇÀ¸·Î Á¦¾à ±â¾÷ ¹× »ý¸í °øÇÐ ±â¾÷Àº ¿ÜºÎ Àü¹® Áö½Ä°ú ¼­ºñ½º¿¡ ´ëÇÑ ÀÇÁ¸¼ºÀ» °­È­Çϰí ÀÖ½À´Ï´Ù. MA(Medical Affairs) ¾Æ¿ô¼Ò½ÌÀº °³¹ß ºñ¿ë Àý°¨, ÀÓ»ó½ÃÇè ¹× ½ÅÁ¦Ç° »ó½ÃÀÇ ¼Óµµ Çâ»ó¿¡ µµ¿òÀÌ µË´Ï´Ù. ±â¾÷Àº ÇÙ½É ¿ª·®¿¡ ÁýÁßÇϸ鼭 ¾Æ¿ô¼Ò½Ì ÆÄÆ®³ÊÀÇ Àü¹® ±â¼ú°ú °ßÇØÀÇ ÇýÅÃÀ» ´©¸± ¼ö ÀÖ½À´Ï´Ù. Á¦°øµÇ´Â ´Ù¾çÇÑ ¼­ºñ½º¿¡´Â ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú ÇÔ²² ÀÇ·á Á¤º¸, ÀÇ·á ¸ð´ÏÅ͸µ, ÀÇ·á º¸°í¼­, ÃâÆÇ °èȹ µîÀÌ Æ÷ÇԵ˴ϴÙ. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¿ø°ÝÁö¿¡¼­ À¯¿¬ÇÑ ÀÛ¾÷ ¸ðµ¨ÀÌ °¡´ÉÇØÁö°í ¾Æ¿ô¼Ò½Ì ¹üÀ§°¡ È®´ëµÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐÈ­ÀÇ Áö¼Ó¼º°ú ÀǾàǰ °³¹ß¿¡ ´ëÇÑ R&D ÅõÀÚÀÇ È®´ë´Â MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ :

¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀåÀÇ ¼ºÀåÀº ÀǾàǰ °³¹ß ºñ¿ëÀÇ »ó½Â, ±ÔÁ¦ ±âÁØÀÇ ¾ö°ÝÈ­, Á¦¾à ±â¾÷¿¡ ÀÇÇÑ ÇÙ½É ¿ª·®¿¡ ´ëÇÑ ÁÖ·Â µî ¿äÀο¡ ÀÇÇØ ÃÊ·¡µË´Ï´Ù. ½Å¾à °³¹ß¿¡ µå´Â Æò±Õ ºñ¿ëÀº Áö³­ ¼ö½Ê³âµ¿¾È »ó´çÈ÷ »ó½ÂÇßÀ¸¸ç, ÇöÀç´Â 26¾ï ´Þ·¯¸¦ ³Ñ°í ÀÖ½À´Ï´Ù. ƯÁ¤ ±â´ÉÀ» ¾Æ¿ô¼Ò½ÌÇÏ¸é ºñ¿ëÀ» Å©°Ô ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦ ¿ä°Çµµ ¼¼°èÀûÀ¸·Î º¹ÀâÇØÁö°í ÀÖÀ¸¸ç, ¼­·ù ÀÛ¼º ¹× ÄÄÇöóÀ̾𽺠±âÁصµ ¾ö°ÝÇØÁö°í ÀÖ½À´Ï´Ù. MA(Medical Affairs) ¾Æ¿ô¼Ò½ÌÀ» ÅëÇØ ±â¾÷Àº Àü¹® Áö½ÄÀ» Ȱ¿ëÇÏ¿© È¿À²ÀûÀ¸·Î ±ÔÁ¦¸¦ ±Øº¹ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºñÁßÇÙ ¾÷¹«¸¦ ¾Æ¿ô¼Ò½ÌÇÔÀ¸·Î½á ±â¾÷Àº º¸´Ù ÇÙ½ÉÀûÀΠâ¾à¡¤¸¶ÄÉÆÃ È°µ¿¿¡ ÁýÁßÇÒ ¼ö ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ º¸¾È ¹× Áß¿äÇÑ ÇÁ·Î¼¼½ºÀÇ °ü¸® ºÒ°¡´É¼ºÀº ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀΰøÁö´É°ú ºí·ÏüÀΰú °°Àº ±â¼úÀû Áøº¸´Â ¿ø°Ý ¼­ºñ½º¿Í µ¥ÀÌÅÍ °ü¸® ´É·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖ´Â ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇÏ¿© 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÑ ¿¹Ãø±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í CAGR(%)À» °ÔÀçÇß½À´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀûÀÎ ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç°ÀÇ »ó½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÏ´Â °æÀï Àü·« µî¿¡ °üÇÑ Áß¿äÇÑ °íÂûµµ Á¦°øÇÕ´Ï´Ù.
  • ¿£ÅÍÇÁ¶óÀÌÁî ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µî°ú °°Àº ¸Å°³º¯¼ö¸¦ ±â¹ÝÀ¸·Î Àü ¼¼°è MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÅëÂûÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, ŸÀÌÇÎ, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô Âü°¡ÀÚ, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº Àü ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤ÀÌ ¿ëÀÌÇØÁý´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû ¹× ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ ¹× ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±Ý Á¶´Þ ¹× ÅõÀÚ
  • PEST ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå : COVID-19ÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎÀÇ ´ëó
  • COVID-19¿¡ ÀÇÇÑ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå, ¼­ºñ½ºº°(2019-2031³â, 10¾ï ´Þ·¯)

  • ¸ÞµðÄà ÀúÀÛ ¹× ÃâÆÇ
  • ¸ÞµðÄà ¸ð´ÏÅ͸µ
  • MSL(Medical Science Liaison)
  • ÀÇ·á Á¤º¸
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå, »ê¾÷º°(2019-2031³â, 10¾ï ´Þ·¯)

  • Á¦¾à
  • ¹ÙÀÌ¿À ÀǾàǰ
  • ÀÇ·á±â±â

Á¦7Àå ¼¼°èÀÇ MA(Medical Affairs) ¾Æ¿ô¼Ò½Ì ½ÃÀå, Áö¿ªº°(2019-2031³â, 10¾ï ´Þ·¯)

  • ³²¹Ì
  • À¯·´
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç
  • Áßµ¿

Á¦8Àå °æÀï ±¸µµ

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • IQVIA Holdings Inc.
    • Ashfield
    • Syneos Health
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Pharmaceutical Product Development(PPD)
    • WuXi AppTec
    • SGS SA
    • Covance Inc.(part of LabCorp)
    • Indegene
    • The Medical Affairs Company(TMAC)
    • Synergy Pharmaceuticals
    • Charles River Laboratories
    • KOLgroups
    • ZS Associates
    • McKinsey &Company(Healthcare Practice)
    • Accenture

Á¦9Àå ¾Ö³Î¸®½ºÆ® Ãßõ

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • ÀϰüµÈ ±âȸ ¸Ê

Á¦10Àå Âü°í¹®Çå ¹× Á¶»ç¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý
LYJ

Global medical affairs outsourcing market is estimated to be valued at USD 2.31 Bn in 2024 and is expected to reach USD 5.21 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.3% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 2.31 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 12.30% 2031 Value Projection: US$ 5.21 Bn
Figure. Medical Affairs Outsourcing Market Share (%), By Region 2024
Medical Affairs Outsourcing Market - IMG1

Rising drug development costs and complex regulatory requirements have compelled pharmaceutical and biotech companies to increasingly rely on external expertise and services. Medical affairs outsourcing helps to reduce development expenses and speeds up clinical trials and new product launches. It allows companies to stay focused on core competencies while benefitting from specialized skills and insights of outsourcing partners. Various services offered include medical information, medical monitoring, medical reporting and publication planning, along with regulatory support. Advancements in technology have enabled remote and flexible working models, thus, boosting the scope of outsourced activities. Continued digitalization and growing R&D investment in drug development can drive the medical affairs outsourcing market growth.

Market Dynamics:

Global medical affairs outsourcing market growth is driven by factors like rising drug development costs, stringent regulatory norms, and focus on core competencies by pharmaceutical firms. The average cost of developing a new drug has increased substantially over the past few decades to over US$ 2.6 billion currently. Outsourcing certain functions helps to lower costs substantially. Regulatory requirements have also become more complex globally with greater paperwork and compliance standards. Medical affairs outsourcing allows companies to leverage specialized expertise to navigate regulations efficiently. It also allows companies to focus more on core drug discovery and marketing activities while non-core functions are outsourced. Data security and loss of control over critical processes can hamper the market growth. Technological advancements like artificial intelligence and blockchain offers opportunities by enabling remote services and greater data management capabilities.

Key Features of the Study:

  • This report provides in-depth analysis of the global medical affairs outsourcing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical affairs outsourcing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Syneos Health, ICON plc, PRA Health Sciences, The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Promedica International, Synchrogenix Information Strategies, Anthelio Healthcare Solutions, Pharmaceutical Product Development, LLC. (PPD), and Clinquest Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical affairs outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • -Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical affairs outsourcing market

Detailed Segmentation-

  • By Services
    • Medical Writing & Publishing
    • Medical Monitoring
    • Medical Science Liaisons (MSLs)
    • Medical Information
    • Others
  • By Industry
    • Pharmaceutical
    • Biopharmaceutical
    • Medical Devices
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • IQVIA Holdings Inc.
    • Ashfield (part of UDG Healthcare plc)
    • Syneos Health
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Pharmaceutical Product Development (PPD)
    • WuXi AppTec
    • SGS SA
    • Covance Inc. (part of LabCorp)
    • Indegene
    • The Medical Affairs Company (TMAC)
    • Synergy Pharmaceuticals
    • Charles River Laboratories
    • KOLgroups
    • ZS Associates
    • McKinsey & Company (Healthcare Practice)
    • Accenture

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services
    • Market Snapshot, By Industry
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Medical Affairs Outsourcing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Medical Affairs Outsourcing Market, By Services, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Medical Writing & Publishing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Science Liaisons (MSLs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Information
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Medical Affairs Outsourcing Market, By Industry, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Pharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Biopharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Medical Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Medical Affairs Outsourcing Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • IQVIA Holdings Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ashfield
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Syneos Health
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Parexel International Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ICON plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PRA Health Sciences
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmaceutical Product Development (PPD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • WuXi AppTec
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SGS SA
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Covance Inc. (part of LabCorp)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Indegene
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • The Medical Affairs Company (TMAC)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Synergy Pharmaceuticals
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • KOLgroups
    • ZS Associates
    • McKinsey & Company (Healthcare Practice)
    • Accenture

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Reference and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦